Minimally Invasive Mapping Guided Surgical Treatment of Atrial Fibrillation. Utopia or Near Future? by van Brakel, Thomas J et al.
 
www.ipej.org 234
Point of View
Minimally Invasive Mapping Guided Surgical Treatment of 
Atrial Fibrillation. Utopia or Near Future?
Thomas J. van Brakel MD, PhD,1 Gil Bolotin MD, PhD,2 M.A. Allessie, MD, PhD,3 Jos G. 
Maessen MD, PhD2
Cardiovascular Research Institute Maastricht, Department of Cardiology1, Cardiothoracic 
Surgery2, and 3Department of Physiology, University Hospital Maastricht, The Netherlands
Address for correspondence:  Thomas J. van Brakel MD, PhD, Department of Cardiology, 
University Hospital Maastricht, The Netherlands Email: t.vanbrakel@ctc.unimaas.nl
Abstract 
            Isolation of the pulmonary veins has been used as surgical treatment for atrial fibrillation 
(AF) from the early 90s, as it was incorporated in the Maze procedure. With the evidence that 
triggers form this area can induce AF, the Maze III procedure has been adapted and modified 
towards a single lesion around the pulmonary veins for the treatment of paroxysmal and chronic 
AF in some centers. New ablation techniques with a diversity of energy sources further paved 
the way for less invasive procedures. Minimal invasive techniques to prevent major surgery may 
potentially make the treatment available for a patient population that does not have to undergo 
cardiac surgery for other reasons. Besides these technical developments, high density mapping 
can be used to identify the AF substrate in the individual patient and optimization of the 
treatment by local substrate guided ablation. This review aims to summarize the robotic and 
thoracoscopic techniques to isolate the pulmonary veins. Furthermore, it is discussed why 
pulmonary veins isolation may be effective in patients with chronic AF, and whether there is a 
role for mapping guided minimal invasive surgical treatment of AF in the near future.
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Introduction
            The Maze procedure was for a long time accepted as the 'gold standard' for the surgical 
treatment of atrial fibrillation (AF) in a selected group of patients1. Although the Maze 
procedure cured AF in most of the patients (approximately 90%) the technique did not find 
widespread application due to its complexity and invasiveness. To overcome these drawbacks, 
the procedure has been adapted and simplified over the last ten years. Techniques such as cryo-, 
radiofrequency- and microwave ablation have shown to be able to replace the time consuming 
cut-and-sew technique of the Maze procedure2-4. Furthermore, epicardial ablation techniques are 
currently explored to be able to perform epicardial ablations on the beating heart2,3,5. The Maze 
procedure and modified procedures were originally based on the multiple wavelet hypothesis 
and aimed to interrupt reentry circuits6,7. Interestingly, together with a change in techniques, an 
important change in theories facilitated the further 'minimalization' of the technique. After 
Haissaguerre et al demonstrated that ectopic foci from the pulmonary veins can initiate AF8, 
surgical treatment of AF concentrated on the pulmonary vein area as the main target area. With 
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the development of minimally invasive techniques, the indication for epicardial pulmonary vein 
ablation has been widened and allows patients with lone AF to be treated via this approach5. 
Endoscopic and robotic procedures are under investigation and already clinically used in some 
centers.
            Most recently it has become clear from epi- and endocardial mapping studies that areas 
with fractionated electograms may be responsible for the perpetuation of AF9. Since the location 
of these areas may differ between patients, mapping for substrate identification, followed by 
substrate  targeting, may  increase  the success percentages of  AF  treatment  significantly. 
Particularly the epicardial approach offers the advantage that the entire surface of both atria be 
reached. Furthermore, the myocardium can be treated outside the circulation, decreasing the risk 
of thromboembolic events and the need for anticoagulants. Although not yet performed, the 
combination of minimally invasive substrate identification by mapping and targeting with 
ablation, may be the treatment of choice for the surgical management of AF in the near future.
Thoracoscopic and Robot-assisted isolation of the pulmonary veins           
              From a historical point of view, the surgical treatment of AF was only considered 
appropriate for patients undergoing cardiac surgery for structural heart diseases, or for patients 
with permanent highly symptomatic AF who are willing to undergo major surgery10,11.  As long 
as the procedure remains invasive, the physical and technical limitations make the epicardial 
approach less interesting as a target for treatment of AF in patients who do not have to undergo 
cardiac surgery. In an attempt to overcome these issues, surgical techniques are adapted and 
refined   using   robotic-endoscopic   techniques.  Table   1  summarizes   the   publications   on 
endoscopic or robotic epicardial treatment of AF.
Table 1: Epicardial robotic/thoracoscopic isolation of the pulmonary veins
 
MW=microwave, LAA=left atrial appendage, EP=electrophysiology, SR=sinus rhythm
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            Standard, minimally invasive methods using thoracoscopy, are characterized by limited 
manoeuverability   of   the   instruments   with   limited   two-dimensional   vision.   The   recent 
developments in robot-assisted surgery may overcome these drawbacks of endoscopic surgery. 
This approach aims to provide three-dimensional vision techniques and simulation of the 
surgeons smooth wrist-finger action, through access ports of less than 1 cm23. Recently, we 
reported a safe right sided chest approach with the da Vinci Robotic Surgical System and 
microwave ablation to isolate the pulmonary veins in dogs (see figure 1)14. Also Smith et al 
reported a minimally invasive beating heart epicardial left AF procedure using monopolar 
microwave energy with the da Vinci Robotic Surgical System13. Although the robotic system 
indeed shows a better manoeuvrability of the instruments with better vision, it might not be 
necessary for this procedure. Several groups have shown fast and safe procedures of epicardial 
beating heart pulmonary vein ablation with direct thoracoscopic instruments without robotic 
assistance19,21,22. Pruitt et al described a totally endoscopic closed-chest microwave mini-Maze 
ablation for the treatment of intermittent and continuous AF with 80% of patients free from AF 
after 8 month of follow up12. Also Salenger et al reported a total endoscopic epicardial procedure 
to isolate the pulmonary veins, with a short length of hospital stay, short procedure time, and 
acceptable rhythm results19. 
 
Figure 1. Robot-assited right chest epicardial isolation of the pulmonary veins. The upper panel 
depicts blunt preparation of the inter-atrial grove. The lower panel shows the introduction of the 
microwave Flex-10 ablation catheter into the transverse sinus.
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Why   pulmonary   vein   ablation?                                                      
            The role of triggering foci originating from the pulmonary veins responsible for the 
initiation of AF, has been well described8,24. Electrical isolation of each pulmonary veins alone, 
without additional lesions to block pathways of reentry, seems to be quite effective in patients 
with paroxysmal AF25,26, although the   results in patients with persistent and permanent AF 
showed rather disappointing results4,27. Gaita et al reported a success percentage of only 25% 
after complete isolation of the pulmonary vein ostia in patients with permanent AF associated 
with valvular heart disease4. Sanders et al demonstrated that termination of AF occurred during 
PV ablation in 17 of 19 with paroxysmal and in 0 of 13 patients with permanent AF28. Although 
direct evidence is lacking, these studies indicate that there is a clear difference in mechanisms 
between paroxysmal and persistent AF. Apparently, the pulmonary veins seem to play an 
important role in paroxysmal but not in persistent AF.   However, this statement can not be 
maintained when the posterior wall of the left atrium, which comprises the pulmonary veins, is 
taken into account. Todd et al showed that the isolated posterior left atrium can sustain AF 
whereas the remaining much larger atrial tissue could not29. They speculated that the anatomy or 
electrophysiology of the pulmonary vein area may promote reentry, resulting in the maintenance 
of   AF.                                                                  
            Furthermore, surgical experiences have shown that 60-80% of patients with persistent 
AF can be treated, regardless of the lesion set and the technique used30. All these techniques and 
lesion sets, however, have one thing in common and that is the involvement of the posterior area 
between the pulmonary veins. The results of these clinical studies are difficult to compare, 
because of differences in patient groups, use of antiarrhythmic agents and clinical endpoints. 
What can be derived from these studies is that only isolation of the PV ostia is not enough to 
cure persistent AF, but that lesions in- or around the posterior left atrium are needed to restore 
sinus rhythm. Gaita et al randomized patients with persistent AF for pulmonary vein ostial 
isolation and pulmonary vein ostial isolation in combination with a 7-shaped lesion on the left 
atrial posterior wall. Interestingly, the low success rate (25%) in the PV group increased to 76% 
in the 7 lesion group (without antiarrhythmic drugs)4. Others also showed that one circular lesion 
around all pulmonary veins in patients with persistent AF and structural heart disease can restore 
sinus   rhythm   50-80%   of   patients3,31.                                                              
Complete   or   incomplete   isolation                                                    
            It is generally believed that irrespective of the type of device or energy source, ablation 
lesions need to be transmural to prevent reentry or triggers from initiating or maintaining AF. 
However, several recent studies showed that in many cases linear ablation lesions around the 
pulmonary veins are electrically or histologically incomplete32-34. Particularly beating heart 
endoscopic or robotic ablation might increase the risk of incomplete isolation, due to endocardial 
blood cooling (or in case of cryo energy warming), and difficult anatomic position of the lesions 
with reduced direct vision of the catheter. In a recent study from our group, complete isolation 
after a single robot-assisted microwave lesion around the pulmonary veins was demonstrated in 
8 out of 16 dogs15. In the study of Smith et al it was concluded that further confirmation of 
catheter positioning is necessary during a right-chest-only robotic approach because lesion 
transmurality was not demonstrated consistently13.                                                       
               Interestingly, most clinical studies of (minimal invasive) surgical isolation of the 
pulmonary veins for AF treatment, reported high percentages of sinus rhythm restoration30 
whereas it may be assumed that a high percentage of lesions are incomplete. This suggests that 
more than isolation of triggers from the pulmonary veins alone is needed to treat patients with 
persistent   AF.                                                                          
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Mapping of the AF substrate as a guide for minimal invasive surgical AF treatment
            AF generally occurs in the presence of an atrial substrate which is the result of structural 
and/or electrical alterations of the tissue (so called remodeling). Experimental and clinical 
studies provided insight into these tissue alterations and showed that different types of 
remodeling are observed in the context of different underlying pathologies (heart failure, rapid 
atrial activation, valvular disease, hypertension etc). To selectively and locally treat patients with 
AF, one of the most important and challenging aspects is to study the mechanisms of AF 
perpetuation in individual patients with different types of atrial remodeling. High density 
epicardial mapping can give insight into this electropathological substrate. From the mapping 
data that were recently collected in our clinics, it is clear that focal activity or a rotor acting as a 
'driver' with  fibrillatory conduction in the posterior left atrium is not a common mechanism in 
patients with persistent AF and structural heart disease. Other types of substrates located in the 
pulmonary vein area need to be considered. Electrical and structural changes of the atria may 
have progressed into a stage, where a rotor or focal source is no longer necessary for the 
perpetuation of AF. Nademanee et al also found complex fractionated electrograms mainly 
confound to the pulmonary veins, the roof of the left atrium and the interatrial septum. Ablation 
of these fractionated areas resulted in restoration of sinus rhythm in the majority of patients9. 
Interestingly, we did observe a higher percentage of fractionated electrograms and dissociated 
small waves in the pulmonary vein area and Bachmanns bundle compared to the remaining 
tissue in the left and right atrium. Figure 2 shows a typical example of fractionated electrograms 
and small streets of dissociated waves recorded from the area in between the pulmonary veins. 
As suggested by Shan et al35, fractionation of electrograms at Bachmann's bundle may be the 
result of dispersion of refractoriness between Bachmann's bundle and the surrounding tissue, or 
it may be the expression of local reentry within Bachmann's bundle. Local reentry in Bachmanns 
Bundle and the pulmonary vein area can act as a perpetuator of fibrillation. Goette et al 
suggested that in diseased atria, fibrosis and fatty degeneration will cause electrical dissociation 
of muscle bundles giving rise to "structurally determined" fractionation36. If indeed this is a 
mechanism in patients with persistent AF, ablation of the fractionated areas will contribute to the 
rate of cardioversion. 
 
Figure 2. Epicardial high density mapping of the area in between the pulmonary veins. The left 
panel depicts the 1 cm2 60 unipolar mapping probe signals of a single time window.  On the 
right side, the wave pattern of this time window is shown. Note the fractionated signals and the 
small streets of dissociated waves.
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            Although the role of fractionation and dissociation in the perpetuation of AF is not yet 
fully elucidated and needs further studies, it might be used as a guide for substrate guided 
ablation. The hand made mapping probe used in our center has 60 electrodes on 1 cm2. With 
some adaptations, this instrument may be easily transformed for endoscopic or robotic mapping 
of atrial fibrillation. With online identification of the fractionated and dissociated fibrillation 
areas, the surgical treatment of AF can shift from an anatomic approach (isolation of the 
pulmonary veins) to a more rationalized substrate based electrophysiologic approach. By 
combining mapping, ablation and minimal invasive techniques, rationalized individually tailored 
surgical treatment of AF may become available for a broader patient population. Whether this 
new approach will gain a widespread clinical application depends on future developments of the 
procedure including procedure time, the cost-benefit profile, and the success of treatment.
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